Migrevention

Migrevention is an Estonian digital health technology company focused on migraine and primary headache management. Headquartered in Tallinn, the company has developed a fully digital headache clinic that connects patients, healthcare specialists, and clinics through innovative digital tools. Their mission is to address the global burden of migraines, which affect around 1.4 billion people worldwide. The company offers a range of services, including the Migrevention Headache App, a free medical device app for tracking headache episodes and medication use. They also provide the Migrevention Patient Manager, a secure platform for healthcare providers to access patient data, and a digital headache clinic pathway that connects patients with a multidisciplinary team of specialists. Additionally, Migrevention supports pharmaceutical research with real-world data and offers corporate wellbeing programs to enhance employee health and productivity. Their approach has shown significant benefits, including reduced doctor visits and improved patient satisfaction.

• Employees 10
• Founded 2020
• Annual Revenue $1500000
• Total Funding $403571